Cell Signaling Technology

Phospho-DAPP1/BAM32 (Tyr139) (D7G4G) Rabbit Monoclonal Antibody

#13703 · $176

92
Citing papers
4k
Combined citations
Supplier page Find this product

Research areas

Cancer, Hypoxia, and Metabolism15Ion Channels and Receptors12Endoplasmic Reticulum Stress and Disease8Metabolism, Diabetes, and Cancer5Glycosylation and Glycoproteins Research5Erythrocyte Function and Pathophysiology5Autophagy in Disease and Therapy5Cancer Immunotherapy and Biomarkers4

Papers citing this product

1
SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm
Microbial Cell Factories·2012·573 cit.·DOI
2
Effects of Body Temperature on Neural Activity in the Hippocampus: Regulation of Resting Membrane Potentials by Transient Receptor Potential Vanilloid 4
Journal of Neuroscience·2007·301 cit.·DOI
3
Chrysin inhibited tumor glycolysis and induced apoptosis in hepatocellular carcinoma by targeting hexokinase-2
Journal of Experimental & Clinical Cancer Research·2017·164 cit.·DOI
4
The NHE1 Na+/H+ Exchanger Recruits Ezrin/Radixin/Moesin Proteins to Regulate Akt-dependent Cell Survival
Journal of Biological Chemistry·2004·162 cit.·DOI
5
Genistein suppresses aerobic glycolysis and induces hepatocellular carcinoma cell death
British Journal of Cancer·2017·160 cit.·DOI
6
Eplerenone Blocks Nongenomic Effects of Aldosterone on the Na+/H+ Exchanger, Intracellular Ca2+ Levels, and Vasoconstriction in Mesenteric Resistance Vessels
Endocrinology·2004·142 cit.·DOI
7
Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria
Nature Communications·2015·138 cit.·DOI
8
Quercetin Inhibits the Proliferation of Glycolysis-Addicted HCC Cells by Reducing Hexokinase 2 and Akt-mTOR Pathway
Molecules·2019·115 cit.·DOI
9
In vitro and in vivo study of epigallocatechin-3-gallate-induced apoptosis in aerobic glycolytic hepatocellular carcinoma cells involving inhibition of phosphofructokinase activity
Scientific Reports·2016·101 cit.·DOI
10
BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM
British Journal of Cancer·2017·96 cit.·DOI